Big update
5 Aug 2026
Q2 2026 quarterly financial results reported
Shows how much money the company made or lost in the first half of 2026.
SEC 10-Q · filed 2026-08-05
View filing ↗
What's happening at MannKind Corporation
MannKind Corporation's latest moves, explained simply — so you know why the numbers change.
Straight from SEC filings · updated 6 Aug 2026
Earnings
5 Aug 2026
Q2 2026 earnings announced August 5
Company released its financial performance results to investors and the public.
SEC 8-K · filed 2026-08-05
View filing ↗
Money
24 Jul 2026
Raised $40.6 million selling 10.4 million shares
Company got cash by selling stock to investors at $3.89 per share.
SEC 8-K · filed 2026-07-24
View filing ↗
Deal
2 Jun 2026
FDA approves Afrezza for children ages 6 and older
Product can now be sold to more patients, potentially increasing future revenue.
SEC 8-K · filed 2026-06-02
View filing ↗
Governance
28 May 2026
FDA releases company from lung cancer safety study requirement
Company no longer needs to conduct expensive five-year study, reducing costs.
SEC 8-K · filed 2026-05-28
View filing ↗
Governance
22 May 2026
Nine directors elected at May 20 annual stockholder meeting
Shareholders voted to keep the current board members running the company.
SEC 8-K · filed 2026-05-22
View filing ↗
Earnings
6 May 2026
Q1 2026 quarterly financial results reported
Shows the company's financial performance in the first three months of 2026.
SEC 10-Q · filed 2026-05-06
View filing ↗
Common questions
How does Stocky track MannKind Corporation's company events?
Stocky reads MannKind Corporation's official filings with the U.S. Securities and Exchange Commission (SEC) — the 8-K, 10-Q and 10-K reports every public company must file — and summarizes each one in plain English, with a link back to the original document.
What was MannKind Corporation's most recent SEC filing?
MannKind Corporation's most recent tracked filing was a 10-Q on 5 Aug 2026: Q2 2026 quarterly financial results reported.
Is this financial advice?
No. These event summaries are educational — generated from public SEC filings to help beginners understand what a company is doing. They are not buy or sell recommendations.